Symbol Lookup

Friday May 22, 2015 4:26 AM ET. Data delayed 15 minutes.
0.10
0.00 (0.00%)
Bid/Lots
0.00/0
Ask/Lots
0.00/0
Open/Prev Close
0.00/0.10
Day Range
-----
52-Week Range
0.07-0.55
Vol/Avg Daily Vol
0.0/781.5K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
FDA Completes Review of Guided Therapeutics' LuViva(R) Advanced Cervical Scan PMA Application
4:05PM ET on Tuesday May 19, 2015 by Business Wire

Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that it has received notification from the U.S. Food and Drug Administration (FDA) regarding the pre-market approval (PMA) application for the LuViva(R) ...

Guided Therapeutics Reports First Quarter 2015 Results
4:05PM ET on Wednesday May 13, 2015 by Business Wire

--FDA response on amended LuViva PMA application expected by end of May

--Primary sales focus is international screening markets with large unmet need

--Several key markets expected to ramp up screening efforts in 2015

County Government of Nairobi, Kenya Purchases Initial LuViva(R) Advanced Cervical Scan for Cervical Cancer Screening Program
8:05AM ET on Wednesday May 06, 2015 by Business Wire

Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), today announced that Stem World Enterprises, its distributor for East Africa, has been awarded a contract with the Nairobi County Health Services Sector to supply the f...

Guided Therapeutics to Report First Quarter 2015 Results and Hold Conference Call; Provide Update on LuViva FDA Timing
8:05AM ET on Wednesday Apr 29, 2015 by Business Wire

Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), developer of a point-of-care and painless testing platform that uses biophotonics for the early detection of disease that leads to cervical cancer, today announc...

Company Information

Guided Therapeutics, Inc. is a medical technology company focused on developing medical devices. The Company’s primary focus is the development of its LuViva non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, especially esophageal. The Company’s technology, including products in research and development, primarily relate to biophotonics technology for the non-invasive detection of cancers. LuViva is a non-invasive cervical cancer detection product, based on the Company's biophotonic technology. The device is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix.  The Company's product, in addition to detecting the structural changes attributed to cervical cancer, is also designed to detect the biochemical changes that precede the development of visual lesions.

CONTACT INFORMATION

Headquarters5835 Peachtree Cors E Ste D
NORCROSS, GA, United States 30092-3413
Phone770-242-8723
Fax--

EXECUTIVE OFFICERS

Independent Chairman and DirectorMichael James
President, Chief Executive Officer and Acting Chief Financial OfficerGene Cartwright
Senior Vice President - EngineeringRichard Fowler
Independent DirectorRonald Hart
Independent DirectorJohn Imhoff

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$10.7MBeta0.50
Revenue (TTM)$823.0KEPS$-0.13
Shares Out.106.8MBook Value$-0.05
Guided Therapeutics Inc does not pay a dividend.P/E--
Price/Sales (TTM)13.0
P/Cash Flow (TTM)--
Operating Margin-1,092.83%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample